Jefferies Group LLC Idera Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.01 - $1.58 $2,314 - $3,621	-2,292 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$1.23 - $5.98 $2,819 - $13,706	2,292 New	2,292 $2,000
Q1 2021 May 14, 2021	BUY	$1.23 - $5.98 $2,819 - $13,706	2,292 New	2,292 $3,000
Q1 2019 May 15, 2019	SELL	$2.33 - $3.79 $36,562 - $59,472	-15,692 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.77 - $9.38 $43,466 - $147,190	15,692 New	15,692 $43,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.